Mitigate Risk, Increase Speed & Reduce Complexity with Customized Single-Use Systems

Webcast

Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.

Register Free: https://www.biopharminternational.com/bp_w/complexity

Event Overview:

Mitigating risk, increasing production speed and reducing complexity are the main drivers in today´s biopharma industry. Parker is addressing those topics through customized single-use systems for biopharma across several processes – vaccines and viral vectors, mAB and other recombinant protein manufacture, and CAGT manufacture. These single-use systems protect processes from contamination with open architecture, are scalable from R&D to full-scale production, and can offer simplification in the supply chain and implementation of single-use technologies.

Key Learning Objectives:

  • Learn how you can protect your product through process enclosures leveraging custom single-use solutions with an open architecture design
  • Hear how single-use systems contribute to solving biopharma process challenges
  • Understand how to eliminate contamination, increase speed, and process flexibility for vaccines, antibodies, therapeutics, and cell and gene therapy processes

Speakers

Dr. Heinz-Christian Rost
Life Science Market Manager
Parker Hannifin

Dr. Heinz Christian Rost is Market Manager of Life Sciences and Winovation Manager. He’s been with Parker since 2011 and during this time, he has held various positions in research & development and was responsible, for the development of the process technology for single-use fluid management systems. In his current position as Market Manager of Life Sciences, he is responsible for the technical and commercial support of customer projects.

Register Free: https://www.biopharminternational.com/bp_w/complexity